ChemBridge Corporation
ChemBridge Corporation offers an extensive portfolio of chemistry products and research services for drug discovery, including small molecule screening libraries, building blocks for medicinal chemists, and discovery chemistry services. Our screening libraries offer over 800,000 leadlike and druglike molecules, including both diverse and targeted/focused screening compounds and selections. For synthesis of advanced molecules for drug discovery, our building block collection provides over 12,000 molecules including aldehydes, carboxylic acids, primary amines, boronic acids, and many other classes. Our chemistry services include custom synthesis, exclusive library synthesis, and FTE-based medicinal chemistry support.
ChemBridge provides a comprehensive portfolio of cost-effective, enabling chemistry solutions for all stages of small molecule drug discovery, from initial hit generation, to hit-to-lead, to lead optimization, and pre-clinical candidate identification.
